David Janerich, DO
Physical Medicine & Rehabilitation · West Pittston, PANPI 1932589843
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.3% of the total across 263 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by Boston Scientific at 30.7% of the total. Among physical medicine & rehabilitation clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 263 payments — averaging $21.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$702
- Collegium Pharmaceutical, Inc.$453
- Ipsen Biopharmaceuticals, Inc$286
- AbbVie$267
- Globus Medical$259
- plus $2K from 25 others
What the payments were for
- Travel & lodging$3065%
- Food & beverage$5,23792%
- Education$1322%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 75 | $1,742 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 42 | $702 |
| Collegium Pharmaceutical, Inc. | 31 | $453 |
| Ipsen Biopharmaceuticals, Inc | 15 | $286 |
| AbbVie(2 entities) | 16 | $267 |
| Globus Medical | 7 | $259 |
| Nevro Corp. | 11 | $245 |
| Abbott | 4 | $231 |
| Si-bone, Inc. | 5 | $229 |
| Biodelivery Sciences International, Inc. | 10 | $149 |
| Medtronic(2 entities) | 5 | $147 |
| Amgen | 1 | $124 |
| Stryker | 2 | $120 |
| Axonics, Inc. | 6 | $91 |
| Biotronik NRO, Inc. | 3 | $90 |
| Revance Therapeutics, Inc. | 5 | $81 |
| Vertos Medical, Inc. | 2 | $67 |
| Almatica Pharma LLC | 3 | $56 |
| Kowa Pharmaceuticals America, Inc. | 3 | $52 |
| Indivior Inc. | 2 | $34 |
| Foundation Fusion Solutions, LLC | 3 | $29 |
| Nalu Medical, Inc. | 1 | $29 |
| Redhill Biopharma Inc. | 2 | $27 |
| Pfizer | 2 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| Alkermes, Inc. | 1 | $27 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Fujifilm Sonosite, Inc. | 1 | $21 |
| Protega Pharmaceutials Inc | 1 | $14 |
| Forte Bio-pharma LLC | 1 | $13 |
| Lundbeck LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL PAIN MANAGEMENT$246
- Senza$145
- Exclaim SCS Leads$132
- AIMOVIG$124
- WaveWriter Alpha Prime 16$123
How this compares
$5,676 in reported general payments places this provider in the 90th percentile of 550 physical medicine & rehabilitation providers in Pennsylvania.
See all physical medicine & rehabilitation providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BotoxOnabotulinumtoxina | 84 | $167,388 |
| DysportAbobotulinumtoxina | 15 | $25,746 |
| Gabapentin | 38 | $487 |
| Tizanidine Hcl | 19 | $175 |
| Pregabalin | 19 | $163 |
| Cyclobenzaprine Hcl | 14 | $141 |
| Diclofenac Sodium | 11 | $132 |
| Celecoxib | 20 | $126 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieBotox | $267 | $167,38884 claims |
| Ipsen Biopharmaceuticals, IncDysport | $286 | $25,74615 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 550 physical medicine & rehabilitation providers in Pennsylvania.
Other physical medicine & rehabilitation in West Pittston
- Albert JanerichWest Pittston$8K
- Jeffery RoweKing Of Prussia$1.9M
- Michael SaulinoElkins Park$425K
- Huaguang QuChalfont$356K
- Alberto EsquenaziPhiladelphia$305K
- Mitchell PaulinPaoli$229K
- Kimberly HeckertPhiladelphia$119K
- David LichtenReading$117K
- Gay WilcherRidley Park$81K
- Jessica MulhernPaoli$79K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.